
#212 Top 10 Highlights of the New Lipid Guidelines
Jul 15, 2026 - 23:52
Radio and PodcastLive Radio & Podcasts
MASLD affects nearly one in three adults worldwide, yet many patients remain undiagnosed until advanced fibrosis or cirrhosis develops. So, which patients should clinicians actually be screening? When is a FIB-4 enough,...
#211 Breaking Down MASLD vs. MASH and the MAESTRO-NASH & ESSENCE Trials: Beyond Journal Club Segment is an episode from Core IM | Internal Medicine Podcast by Core IM Team. MASLD affects nearly one in three adults worldwide, yet many patien...
This episode belongs to Core IM | Internal Medicine Podcast.
Use the player on this page to stream the episode online.
Published Jun 29, 2026, 33:40 long, audio available.